- Home
- CTSO vs OM Comparison
CTSO vs OM Comparison
Compare CTSO & OM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTSO
- OM
- Stock Information
- Founded
- CTSO 1997
- OM 2003
- Country
- CTSO United States
- OM United States
- Employees
- CTSO N/A
- OM N/A
- Industry
- CTSO Medical/Dental Instruments
- OM Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- CTSO Health Care
- OM Health Care
- Exchange
- CTSO Nasdaq
- OM Nasdaq
- Market Cap
- CTSO 68.2M
- OM 50.5M
- IPO Year
- CTSO N/A
- OM 2020
- Fundamental
- Price
- CTSO $0.87
- OM $15.88
- Analyst Decision
- CTSO Strong Buy
- OM Buy
- Analyst Count
- CTSO 3
- OM 2
- Target Price
- CTSO $4.67
- OM $29.50
- AVG Volume (30 Days)
- CTSO 138.7K
- OM 136.5K
- Earning Date
- CTSO 05-14-2025
- OM 05-07-2025
- Dividend Yield
- CTSO N/A
- OM N/A
- EPS Growth
- CTSO N/A
- OM N/A
- EPS
- CTSO N/A
- OM N/A
- Revenue
- CTSO $35,594,520.00
- OM $115,273,000.00
- Revenue This Year
- CTSO $18.72
- OM $8.98
- Revenue Next Year
- CTSO $19.75
- OM $12.74
- P/E Ratio
- CTSO N/A
- OM N/A
- Revenue Growth
- CTSO 14.51
- OM N/A
- 52 Week Low
- CTSO $0.70
- OM $5.85
- 52 Week High
- CTSO $1.61
- OM $78.30
- Technical
- Relative Strength Index (RSI)
- CTSO 33.89
- OM 71.33
- Support Level
- CTSO $0.87
- OM $11.19
- Resistance Level
- CTSO $1.16
- OM $12.79
- Average True Range (ATR)
- CTSO 0.07
- OM 1.18
- MACD
- CTSO -0.02
- OM 0.34
- Stochastic Oscillator
- CTSO 0.00
- OM 92.12
About CTSO Cytosorbents Corporation
CytoSorbents Corp specializes in treating life-threatening conditions in intensive care and cardiac surgery using proprietary polymer adsorption technology. Its flagship product, CytoSorb, is approved in the EU as an extracorporeal cytokine absorber, aiming to reduce inflammation and prevent multiple organ failure in critical illnesses like sepsis and trauma. Revenue primarily comes from product sales in Germany, with additional income from grant agencies in the United States. The company operates through Direct sales and Distributors/strategic partners in United States, Germany and Other Countries. The company's product consists of Cytosorb, ECOS-300CY, VetResQ, HemoDefend, and DrugSorb-ATR.
About OM Outset Medical Inc.
Outset Medical Inc is a medical technology company. It has developed a machine, Tablo, which reduces the cost and complexity of dialysis. Tablo provides Renal Replacement Therapy in Hospitals, Chronic Care in Dialysis Clinics and Home Dialysis.